Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1999, Apple Tree Partners (ATP) is a U.S.-based venture capital firm focused on life sciences. The firm has a portfolio of 30 companies and provides flexible capital and strategic resources to build sustainable, research-driven enterprises.
ATP invests in life sciences companies at various stages, from seed through IPO. Their strategy includes collaborating with scientists on pre-IP ideas and facilitating spinouts from existing company pipelines.
Notable portfolio companies include Aethon Therapeutics, Aileron Therapeutics, Akero Therapeutics, Apertor Pharmaceuticals, Ascidian Therapeutics, Aulos Bioscience, Braeburn, Chinook Therapeutics, Coelacanth, Corvidia Therapeutics, Cyrano Sciences, Deep Apple Therapeutics, Evercrisp Biosciences, Galvanize Therapeutics, Gloucester Pharmaceuticals, HeartWare International, Initial Therapeutics, Marengo Therapeutics, Marlinspike Therapeutics, Nereid Therapeutics, Nine Square Therapeutics, Red Queen Therapeutics, Replicate Bioscience, SGX Pharmaceuticals, Stoke Therapeutics, Syntimmune, Tendyne, Tokai Pharmaceuticals, Tusker Medical, and VytronUS.
Email info@appletreepartners.com with your deck to pitch ATP.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.